These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28477151)

  • 1. Coagulation Testing in Intracerebral Hemorrhage Related to Non-vitamin K Antagonist Oral Anticoagulants.
    Purrucker JC; Rizos T; Haas K; Wolf M; Khan S; Heuschmann PU; Veltkamp R;
    Neurocrit Care; 2017 Oct; 27(2):208-213. PubMed ID: 28477151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation Testing in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants.
    Purrucker JC; Haas K; Rizos T; Khan S; Poli S; Kraft P; Kleinschnitz C; Dziewas R; Binder A; Palm F; Jander S; Soda H; Heuschmann PU; Veltkamp R;
    Stroke; 2017 Jan; 48(1):152-158. PubMed ID: 27899756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants.
    Purrucker JC; Haas K; Rizos T; Khan S; Wolf M; Hennerici MG; Poli S; Kleinschnitz C; Steiner T; Heuschmann PU; Veltkamp R
    JAMA Neurol; 2016 Feb; 73(2):169-77. PubMed ID: 26660118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.
    Boulouis G; Morotti A; Pasi M; Goldstein JN; Gurol ME; Charidimou A
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):263-270. PubMed ID: 29030422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
    Cerebrovasc Dis; 2020; 49(2):177-184. PubMed ID: 32320990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage.
    Gerner ST; Kuramatsu JB; Sembill JA; Sprügel MI; Hagen M; Knappe RU; Endres M; Haeusler KG; Sobesky J; Schurig J; Zweynert S; Bauer M; Vajkoczy P; Ringleb PA; Purrucker JC; Rizos T; Volkmann J; Müllges W; Kraft P; Schubert AL; Erbguth F; Nueckel M; Schellinger PD; Glahn J; Knappe UJ; Fink GR; Dohmen C; Stetefeld H; Fisse AL; Minnerup J; Hagemann G; Rakers F; Reichmann H; Schneider H; Rahmig J; Ludolph AC; Stösser S; Neugebauer H; Röther J; Michels P; Schwarz M; Reimann G; Bäzner H; Schwert H; Claßen J; Michalski D; Grau A; Palm F; Urbanek C; Wöhrle JC; Alshammari F; Horn M; Bahner D; Witte OW; Günther A; Hamann GF; Engelhorn T; Lücking H; Dörfler A; Schwab S; Huttner HB
    Stroke; 2019 Jun; 50(6):1392-1402. PubMed ID: 31092170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of FEIBA in Reversing Novel Oral Anticoagulants in Intracerebral Hemorrhage.
    Dibu JR; Weimer JM; Ahrens C; Manno E; Frontera JA
    Neurocrit Care; 2016 Jun; 24(3):413-9. PubMed ID: 26545367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.
    Seiffge DJ; Hooff RJ; Nolte CH; Béjot Y; Turc G; Ikenberg B; Berge E; Persike M; Dequatre-Ponchelle N; Strbian D; Pfeilschifter W; Zini A; Tveiten A; Næss H; Michel P; Sztajzel R; Luft A; Gensicke H; Traenka C; Hert L; Scheitz JF; De Marchis GM; Bonati LH; Peters N; Charidimou A; Werring DJ; Palm F; Reinhard M; Niesen WD; Nagao T; Pezzini A; Caso V; Nederkoorn PJ; Kägi G; von Hessling A; Padjen V; Cordonnier C; Erdur H; Lyrer PA; Brouns R; Steiner T; Tatlisumak T; Engelter ST;
    Circulation; 2015 Sep; 132(13):1261-9. PubMed ID: 26232277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage.
    Gerner ST; Kuramatsu JB; Sembill JA; Sprügel MI; Endres M; Haeusler KG; Vajkoczy P; Ringleb PA; Purrucker J; Rizos T; Erbguth F; Schellinger PD; Fink GR; Stetefeld H; Schneider H; Neugebauer H; Röther J; Claßen J; Michalski D; Dörfler A; Schwab S; Huttner HB;
    Ann Neurol; 2018 Jan; 83(1):186-196. PubMed ID: 29314216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebral Hematoma Occurring During Warfarin Versus Non-Vitamin K Antagonist Oral Anticoagulant Therapy.
    Takahashi H; Jimbo Y; Takano H; Abe H; Sato M; Fujii Y; Aizawa Y
    Am J Cardiol; 2016 Jul; 118(2):222-5. PubMed ID: 27289294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
    Adachi T; Hoshino H; Takagi M; Fujioka S;
    Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral Hemorrhage.
    Lioutas VA; Goyal N; Katsanos AH; Krogias C; Zand R; Sharma VK; Varelas P; Malhotra K; Paciaroni M; Sharaf A; Chang J; Karapanayiotides T; Kargiotis O; Pappa A; Mai J; Pandhi A; Schroeder C; Tsantes A; Mehta C; Kerro A; Khan A; Mitsias PD; Selim MH; Alexandrov AV; Tsivgoulis G
    Stroke; 2018 Oct; 49(10):2309-2316. PubMed ID: 30355114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial.
    Polymeris AA; Karwacki GM; Siepen BM; Schaedelin S; Tsakiris DA; Stippich C; Guzman R; Nickel CH; Sprigg N; Kägi G; Vehoff J; Barinka F; Thilemann S; Maurer M; Wagner B; Traenka C; Gensicke H; De Marchis GM; Bonati LH; Fischer U; Z'Graggen WJ; Nedeltchev K; Wegener S; Baumgartner P; Engelter ST; Seiffge DJ; Peters N; Lyrer PA;
    Stroke; 2023 Sep; 54(9):2223-2234. PubMed ID: 37466000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage.
    Tsivgoulis G; Wilson D; Katsanos AH; Sargento-Freitas J; Marques-Matos C; Azevedo E; Adachi T; von der Brelie C; Aizawa Y; Abe H; Tomita H; Okumura K; Hagii J; Seiffge DJ; Lioutas VA; Traenka C; Varelas P; Basir G; Krogias C; Purrucker JC; Sharma VK; Rizos T; Mikulik R; Sobowale OA; Barlinn K; Sallinen H; Goyal N; Yeh SJ; Karapanayiotides T; Wu TY; Vadikolias K; Ferrigno M; Hadjigeorgiou G; Houben R; Giannopoulos S; Schreuder FHBM; Chang JJ; Perry LA; Mehdorn M; Marto JP; Pinho J; Tanaka J; Boulanger M; Al-Shahi Salman R; Jäger HR; Shakeshaft C; Yakushiji Y; Choi PMC; Staals J; Cordonnier C; Jeng JS; Veltkamp R; Dowlatshahi D; Engelter ST; Parry-Jones AR; Meretoja A; Mitsias PD; Alexandrov AV; Ambler G; Werring DJ
    Ann Neurol; 2018 Nov; 84(5):694-704. PubMed ID: 30255970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
    Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
    JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of intracerebral hemorrhage associated with different oral anticoagulants.
    Wilson D; Seiffge DJ; Traenka C; Basir G; Purrucker JC; Rizos T; Sobowale OA; Sallinen H; Yeh SJ; Wu TY; Ferrigno M; Houben R; Schreuder FHBM; Perry LA; Tanaka J; Boulanger M; Al-Shahi Salman R; Jäger HR; Ambler G; Shakeshaft C; Yakushiji Y; Choi PMC; Staals J; Cordonnier C; Jeng JS; Veltkamp R; Dowlatshahi D; Engelter ST; Parry-Jones AR; Meretoja A; Werring DJ;
    Neurology; 2017 May; 88(18):1693-1700. PubMed ID: 28381513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar outcomes between vitamin K and non-vitamin K antagonist oral anticoagulants associated intracerebral hemorrhage.
    Chen SJ; Yeh SJ; Tang SC; Lin SY; Tsai LK; Jeng JS
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):106-112. PubMed ID: 30876786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K antagonists but not non-vitamin K antagonists in addition on antiplatelet therapy should be associated with increase of hematoma volume and mortality in patients with intracerebral hemorrhage: A sub-analysis of PASTA registry study.
    Nomura K; Suda S; Abe A; Iguchi Y; Yagita Y; Kanzawa T; Okubo S; Fujimoto S; Kimura K;
    J Neurol Sci; 2023 May; 448():120643. PubMed ID: 37028263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebral Hemorrhagic Expansion Occurs in Patients Using Non-Vitamin K Antagonist Oral Anticoagulants Comparable with Patients Using Warfarin.
    Melmed KR; Lyden P; Gellada N; Moheet A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1874-1882. PubMed ID: 28647419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.